219 related articles for article (PubMed ID: 25693652)
1. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
Dias C; Abosaleem B; Crispino C; Gao B; Shaywitz A
AAPS PharmSciTech; 2015 Oct; 16(5):1101-7. PubMed ID: 25693652
[TBL] [Abstract][Full Text] [Related]
2. A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.
Portron A; Jordan P; Draper K; Muenzer C; Dickerson D; van Iersel T; Hofmann C
Clin Ther; 2020 Jan; 42(1):108-120.e1. PubMed ID: 31883703
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers.
Berges A; Walls C; Lener SE; McDonald SA
Clin Ther; 2010 Jun; 32(6):1165-77. PubMed ID: 20637969
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Injection Site Pain of Formulation Matrices.
Shi GH; Pisupati K; Parker JG; Corvari VJ; Payne CD; Xu W; Collins DS; De Felippis MR
Pharm Res; 2021 May; 38(5):779-793. PubMed ID: 33942212
[TBL] [Abstract][Full Text] [Related]
5. Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates
.
Jain M; Doughty D; Clawson C; Li X; White N; Agoram B; van der Merwe R
Int J Clin Pharmacol Ther; 2017 Jul; 55(7):606-620. PubMed ID: 28590244
[TBL] [Abstract][Full Text] [Related]
6. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects.
Dang X; Shih H; Sharma R; Angwin-Kaerner DT; Lin K; Kapur S; Thyagarajapuram NR; Shi GH; Collins DS
Pharm Res; 2024 Apr; 41(4):751-763. PubMed ID: 38443633
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa.
Pannier A; Jordan P; Dougherty FC; Bour F; Reigner B
Curr Med Res Opin; 2007 Dec; 23(12):3025-32. PubMed ID: 17961301
[TBL] [Abstract][Full Text] [Related]
8. Pain assessment of subcutaneous injections.
Jørgensen JT; Rømsing J; Rasmussen M; Møller-Sonnergaard J; Vang L; Musaeus L
Ann Pharmacother; 1996; 30(7-8):729-32. PubMed ID: 8826549
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
[TBL] [Abstract][Full Text] [Related]
10. Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers.
Zheng Y; Abuqayyas L; Megally A; Fuhr R; Sałapa K; Downie J; Colice G
Clin Ther; 2021 Jan; 43(1):142-155.e5. PubMed ID: 33380362
[TBL] [Abstract][Full Text] [Related]
11. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
Westhovens R; Houssiau F; Joly J; Everitt DE; Zhu Y; Sisco D; Van Hartingsveldt B; Mascelli MA; Graham MA; Durez P; Bouman-Thio E
J Rheumatol; 2006 May; 33(5):847-53. PubMed ID: 16583466
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries.
Mathaes R; Koulov A; Joerg S; Mahler HC
J Pharm Sci; 2016 Aug; 105(8):2255-9. PubMed ID: 27378678
[TBL] [Abstract][Full Text] [Related]
13. A trial comparing local pain after subcutaneous injection of epoetin-beta versus darbepoetin-alpha in healthy volunteers.
Berthoux F; Ryckelynck JP; Rouanet S; Gelu-Mantoulet S; Montestruc F; Mouchel P; Choukroun G;
Clin Nephrol; 2008 Jul; 70(1):33-40. PubMed ID: 18793546
[TBL] [Abstract][Full Text] [Related]
14. Pain perception after subcutaneous injections of media containing different buffers.
Laursen T; Hansen B; Fisker S
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):218-21. PubMed ID: 16445598
[TBL] [Abstract][Full Text] [Related]
15. An Innovative Needle-free Injection System: Comparison to 1 ml Standard Subcutaneous Injection.
Kojic N; Goyal P; Lou CH; Corwin MJ
AAPS PharmSciTech; 2017 Nov; 18(8):2965-2970. PubMed ID: 28462463
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults.
Woodley WD; Morel DR; Sutter DE; Pettis RJ; Bolick NG
Clin Transl Sci; 2022 Jan; 15(1):92-104. PubMed ID: 34268888
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects.
Aoki I; Ishikawa K; Wakana A; Aso M; Yoshinari T
J Infect Chemother; 2015 Mar; 21(3):170-5. PubMed ID: 25572140
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance.
Berteau C; Filipe-Santos O; Wang T; Rojas HE; Granger C; Schwarzenbach F
Med Devices (Auckl); 2015; 8():473-84. PubMed ID: 26635489
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
20. The influence of injection speed on pain during injection of local anaesthetic.
Tangen LF; Lundbom JS; Skarsvåg TI; Wågø KJ; Ballo S; Hjelseng T; Finsen V
J Plast Surg Hand Surg; 2016; 50(1):7-9. PubMed ID: 26414074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
